
Sign up to save your podcasts
Or


Are you ready for the evolving treatment paradigm in HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC)?
Credit available for this activity expires: 10/24/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-gastroesophageal-adenocarcinoma-and-biliary-2025a1000sr3?&ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
Are you ready for the evolving treatment paradigm in HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC)?
Credit available for this activity expires: 10/24/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-gastroesophageal-adenocarcinoma-and-biliary-2025a1000sr3?&ecd=bdc_podcast_libsyn_mscpedu

141 Listeners

700 Listeners

501 Listeners

168 Listeners

101 Listeners

881 Listeners

13 Listeners

16 Listeners

296 Listeners

261 Listeners

3,370 Listeners

1,152 Listeners

193 Listeners

92 Listeners

514 Listeners

368 Listeners

171 Listeners

61 Listeners

8 Listeners

426 Listeners